Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2015 1
2016 2
2018 1
2019 3
2020 3
2021 3
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
Pieber TR, Arfelt KN, Cailleteau R, Hart M, Kar S, Mursic I, Svehlikova E, Urschitz M, Haahr H. Pieber TR, et al. Among authors: svehlikova e. Diabetologia. 2023 Aug;66(8):1413-1430. doi: 10.1007/s00125-023-05921-8. Epub 2023 Jun 13. Diabetologia. 2023. PMID: 37308751 Free PMC article. Clinical Trial.
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus.
Obermayer A, Tripolt NJ, Aziz F, Högenauer C, Aberer F, Schreiber F, Eherer A, Sourij C, Stadlbauer V, Svehlikova E, Brunner M, Goswami N, Kojzar H, Pferschy PN, Pieber TR, Sourij H. Obermayer A, et al. Among authors: svehlikova e. Biomolecules. 2021 Apr 14;11(4):574. doi: 10.3390/biom11040574. Biomolecules. 2021. PMID: 33919949 Free PMC article.
Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes.
Svehlikova E, Ashcroft NL, Gatschelhofer C, Gerring D, Höller V, Jezek J, Lackner B, Lawrence F, Pillai V, Ratzer M, Urschitz M, Wolf M, Pieber TR. Svehlikova E, et al. Diabetes Care. 2023 Apr 1;46(4):757-764. doi: 10.2337/dc22-1054. Diabetes Care. 2023. PMID: 36710473 Free PMC article. Clinical Trial.
Blood glucose response after oral lactulose intake in type 2 diabetic individuals.
Pieber TR, Svehlikova E, Mursic I, Esterl T, Wargenau M, Sartorius T, Pauly L, Schwejda-Guettes S, Neumann A, Faerber V, Stover JF, Gaigg B, Kuchinka-Koch A. Pieber TR, et al. Among authors: svehlikova e. World J Diabetes. 2021 Jun 15;12(6):893-907. doi: 10.4239/wjd.v12.i6.893. World J Diabetes. 2021. PMID: 34168736 Free PMC article.
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.
Aberer F, Pferschy PN, Tripolt NJ, Sourij C, Obermayer AM, Prüller F, Novak E, Reitbauer P, Kojzar H, Prietl B, Kofler S, Brunner M, Svehlikova E, Stojakovic T, Scharnagl H, Oulhaj A, Aziz F, Riedl R, Sourij H. Aberer F, et al. Among authors: svehlikova e. Diabetes Obes Metab. 2020 Feb;22(2):212-221. doi: 10.1111/dom.13889. Epub 2019 Nov 3. Diabetes Obes Metab. 2020. PMID: 31595635 Free PMC article. Clinical Trial.
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes.
Svehlikova E, Mursic I, Augustin T, Magnes C, Gerring D, Jezek J, Schwarzenbacher D, Ratzer M, Wolf M, Howell S, Zakrzewski L, Urschitz M, Tschapeller B, Gatschelhofer C, Feichtner F, Lawrence F, Pieber TR. Svehlikova E, et al. Diabetes Care. 2021 Feb;44(2):448-455. doi: 10.2337/dc20-1017. Epub 2020 Dec 16. Diabetes Care. 2021. PMID: 33328285 Free PMC article. Clinical Trial.
15 results